About Lysosomal Therapeutics

Company Website: http://lysosomaltx.com

Lysosomal Therapeutics Inc. (LTI) is dedicated to innovative small-molecule research and development in the field of neurodegeneration, yielding new treatment options for patients with severe neurological diseases. Our strategy leverages the clinically-validated link between lysosome-based genetic disorders and neurodegenerative diseases to establish a unique and effective molecular platform for novel drug discovery. LTI’s lead program targets Gaucher-related neurodegeneration, Parkinson’s disease and other synucleinopathies.

Current Openings

Lysosomal Therapeutics has no jobs listed. Checkout our job board for opportunities at top VC-backed startups.